Custos Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Buy
1,661
+60
+4% +$14K 0.25% 47
2026
Q1
$391K Buy
1,601
+340
+27% +$79.2K 0.27% 44
2025
Q4
$261K Buy
1,261
+3
+0.2% +$593 0.18% 55
2025
Q3
$233K Buy
+1,258
New +$216K 0.13% 59
2022
Q2
Sell
-1,474
Closed -$261K 27
2022
Q1
$261K Buy
1,474
+227
+18% +$38.6K 0.21% 21
2021
Q4
$213K Buy
+1,247
New +$204K 0.19% 30

Other funds holding JNJ

Custos Family Office's JNJ Position: Q2 2026 in Review

Custos Family Office increased its Johnson & Johnson (JNJ) stake by 3.7% in Q2 2026, buying an estimated $14K and bringing the position to 1,661 shares worth $422K. The position accounts for 0.25% of the portfolio, ranked #47.

Custos Family Office first reported a position in JNJ in Q4 2021 and has held it in 6 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Custos Family Office held 1,661 shares of Johnson & Johnson worth $422K as of Q2 2026.
  • Custos Family Office bought 60 Johnson & Johnson shares in Q2 2026, an estimated $14K.
  • Johnson & Johnson made up 0.25% of Custos Family Office's portfolio in Q2 2026, its #47 holding.
  • Custos Family Office first reported a position in Johnson & Johnson in Q4 2021 and has held it in 6 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Custos Family Office's 13F filing for Q2 2026, filed 19 Aug 2026.